Introduction
Peptides containing one or more residues of an α,α-dialkyl glycine are conformationally constrained owing to restriction of their conformational freedom imparted by the α-alkyl substituents. This conformational rigidity is a requirement to increase potency and selectivity, to improve bioavailabitlity, and to enhance the resistance to peptidases. 1 In addition, the design of conformational constrained sequences is one of the approaches for development of bioactive peptides with high activity and selectivity towards a specific receptor. 2 Deltorfin and Leuenkephalin analogues containing α,α-dialkyl glycine residues are examples of this strategy. 3, 4 Thus, α,α-dialkyl glycines are interesting building blocks for modification of peptides as probes to investigate biologically active conformations and as models for conformational analysis of the peptide backbone (formation of α-or 3 10 -helices, or β-turns). It has been observed by X-ray crystallography that a residue of α-aminoisobutyric acid (Aib) stabilizes type II β-turn conformations in peptides having 2-4 residues; 5 it is also known [6] [7] [8] that when inserted in peptides Aib imparts them a 3 10 -helical conformation, while α,α-diethyl glycine and α,α-dipropyl glycine convey fully planar C 5 conformation. Bulkier substituents (diethyl, di-npropyl) favor both fully extended structures and folded helical conformations in crystal structures. [9] [10] [11] However, it has been also reported that the local sequence may influence the conformation adopted at the disubstituted residue. 12 It is part of our program concerning this class of amino acids to investigate the effect of incorporation of derivatives with side chains larger than methyl into biological active compounds. Now, we present the synthesis and the results of an investigation by 1 H NMR spectroscopy in connection with molecular mechanics calculations of the conformational behavior of four tetrapeptide analogues of the sequence B23-B26 of insulin having an α,α-dialkyl glycine residue at their C-terminus. A considerable number of insulin analogues has been designed by substituting amino acid residues within its B23-B30 sequence (GlyB23-PhePhe-Tyr-Thr-Pro-Lys-ThrB30). These studies revealed that B26-des-(B27-B30)-insulin-NH 2 exhibits full potency, and modification at the its N-terminus, that is, at position B26, may cause dramatic changes in its binding activity. For example, replacement of B-26-tyrosine by D-Ala raised the receptor affinity to 1250%. In addition, it has been proposed that binding of insulin to its receptor needs a conformational change. 13 Owing to steric hindrance related to the tetrasubstitution at their α-carbon atom, α,α-dialkyl glycines are problematic compounds with regard both to their synthesis and to insertion into peptide chains. Nevertheless, we have been engaged in developing an improved synthesis of these amino acids 14 and reports can be found in literature of incorporation of such compounds into peptides by taking advantage of various coupling reagents with different efficiencies. [15] [16] [17] [18] [19] 2. Results and discussion
Synthesis
N-tert-Butyloxycarbonyl-dimethyl and diethyl glycine, and N-benzyloxycarbonyl-dipropyl and di-isobutyl glycine were treated with DCC/HOBt followed by reaction with an aqueous solution of ammonium hydroxide 20 to give the corresponding N-acylamino acid amides in yields of 78, 54, 63 and 75%, respectively. Quantitative cleavage of the N-protecting groups and coupling to N-Boc-phenylalanine by the DCC "pre-mix" procedure with the formation of the symmetrical anhydride in situ; 17 gave the fully protected dipeptides in yields of 83, 76, 83 and 50%, respectively. The fully protected tetrapeptides Boc-Gly-Phe1-Phe2-X-NH 2 , with X = α,α-dimethyl glycine (Aib), α,α-diethyl glycine (Deg), α,α-dipropyl glycine (Dpg) and α,α-diisobutyl glycine (Dbg), were then obtained by a stepwise procedure as shown in Scheme 1 in overall yields of 32, 22, 22 and 12%, respectively, from the N-protected amino acids. These were prepared in yields varying within the range 43-68%, with exception of diethyl glycine derivative, which was commercially available. JαH-NH = 6.7 cos2(φ -60) -1.3 cos (φ -60) + 1.5, the dihedral angles φ were calculated from the NH-CH coupling constants measured in the 1 H spectra (Fig. 1 , Table 1 ).
Plots of chemical shifts versus temperature were obtained for all four compounds from spectra run at various temperatures within the range 298-333 K. These were linear and allowed to calculate the variation of the amide proton chemical shifts with temperature, ∆δ/∆T, which are shown in Table 1 . Chemical exchange of the NH 2 amide protons at the C-terminal was observed on heating. 22 we assume that the Phe 2 amide group has an external orientation. In contrast, the low temperature coefficient, ∆δ/∆T, observed for the α,α-dialkyl glycine NH proton in compounds 2-4 is in agreement with its participation in intramolecular hydrogen bonding; this effect is more pronounced in the case of compounds 3 and 4 (∆δ/∆T= -1.8 ppb K -1 ), which have the largest side chains at their C-terminal residue. Compound 1 behaves differently; the NH proton of its Aib residue is sensitive to temperature (Table 1 , ∆δ/∆T = -5.8 ppb K-1), and may be solvent exposed, and its glycine amide proton (∆δ/∆T = -3.8 ppb K -1
), may be involved in a weak intramolecular hydrogen bond. Based on the NMR data presented above, we propose that peptides 2-4 assume a conformation stabilized by an intramolecular hydrogen bond involving the NH proton of the α,α-dialkyl glycine residue and the carbonyl oxygen atom of Phe 1 to
give rise to a seven-membered ring structure ( Figure 2 ). This does not seem to apply to compound 1, for which our NMR data is inconclusive. A systematic conformational search of each of the tetrapeptides was performed using the glycine r mechanics calculations for all compounds but one were Hyperchem7.0 molecular modeling software and the AMBER force field by varying the dihedral angles of the glycine and phenylalanine residues; the set of minimum energy conformations obtained was then re-optimized with the same force field. The resulting conformations were examined and those consistent with J αH-NH coupling constants and hydrogen bond patterns derived from NMR data were selected as the most probable conformations in solution ( Figure 3 ). In the case of compounds 2-4 a hydrogen bond between NH proton of the α,α-dialkyl glycine residue and the carbonyl oxygen atom of Phe 1 was found, the dihedral angles calculated being close to the experimental values. The conformations calculated for these three compounds are similar and show a bend in agreement with the proposed structure that may be due to repulsive interaction of the two aromatic rings with each other. For compound 1 no intramolecular hydrogen bonding was found, but a bent conformation was also obtained. In this conformation, the values found for the diedral angles were close to the experimental ones; in addition, the NOEs observed were consistent with the calculated structure, as the distances between the interacting atoms for which NOEs were observed varied from 2.1 to 2.9 Å.
The tetrapeptide analogues of fragment B23-B26 of insulin having an α,α-dialkyl residue at the C-terminus could be obtained by DCC promoted stepwise synthesis. The use of the DCC "pre-mix" technique proved to be efficient in the problematic coupling of Boc-Phe to the α,α-dialkyl glycine amide.
Both NMR data and molecula consistent with a folded γ-turn type conformation stabilised by an intramolecular hydrogen bond; this involves the NH proton of the α,α-dialkyl glycine residue and the carbonyl oxygen atom of the first phenylalanine residue. The exception was the peptide having the smallest side chains at the C-terminal residue, that is, the Aib derivative (1), which exhibited a different folded conformation without intramolecular hydrogen bonding. Our results indicate that substitution of methyl at the α,α-dialkyl C-terminal residue by larger groups changes the conformational preferences of these compounds. Little conformational change was observed on branching at the β-carbon. 
Experimental
Melting points were determined on a Gallenkamp melting point apparatus and are uncorrected.
Thin layer chromatography was carried out on pre-coated plates (Merck Kieselgel 60F 254 ) and compounds were visualized by UV-light and exposure to vaporized iodine and to ninhydrin reagent. instrument. Commercially available compounds, including Boc-Deg-OH, and solvents were used without previous purification; light petroleum refers to the fraction boiling at 40-60 ºC; the hydrobromides of α,α-dipropyl and α,α-di-isobutyl glycine were synthesized in our laboratories by a Ugi-Passerini reaction as published elsewhere 14 and Boc-Phe-OH was synthesized by the standard method. 
Boc-Gly-Phe-Phe-Dpg-NH 2 (3)
Z-Dpg-OH. The amino acid hydrobromide (10,8 mmol, 2.12 g) was dissolved in 1 M NaOH (21.6 ml) and stirred with cooling in an ice bath. A solution of benzyl chloroformate was added dropwise with the pH kept at 11 by addition of 1M NaOH under vigorous stirring; the temperature was then raised to 40 ºC and maintained as such for 4 hours, while the pH was kept at 11. The mixture was then extracted with four portions of ethyl ether, the aqueous layer cooled and the pH adjusted to 1.5 by addition of 6 M HCl. The oil thus formed was extracted into ethyl acetate and the solution dried over MgSO 4 . The solvent was removed under reduced pressure to
give an oil that crystallized on standing. Yield 68%, mp. 76-78 ºC. 
